37 research outputs found
Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy.
No full textN-Terminal-probrain natriuretic peptide (NT-proBNP) plasma levels are elevated in patients with congestive heart failure. Published data concerning the utility of NT-proBNP in hypertrophic cardiomyopathy (HCM) are lacking. Our aim was to evaluate the clinical significance of NT-proBNP in patients with HCM. A blood sample was collected for plasma NT-proBNP measurement from 43 consecutive patients with documented HCM. NT-proBNP was measured using a chemiluminescent immunoassay kit (Roche Diagnostics) on an Elecsys 2010 analyzer. Median value of NT-proBNP was 219 pg/ml (range 8-3 045 pg/ml) in NYHA class I patients, 698 pg/ml (125-2 463 pg/ml) in NYHA class II patients, and 2 683 pg/ml (131-11 542 pg/ml) in NYHA class III and IV patients. NT-proBNP plasma levels were significantly higher across the severity of functional limitation (i.e., NYHA class classification) (P = 0.002). NT-proBNP levels were significantly higher in female than male (P = 0.034), in referral vs nonreferral patients (P = 0.004), in symptomatic vs asymptomatic patients (P = 0.020), in patients with basal subaortic gradient >or=30 mmHg (P = 0.001) and in the patients who were on cardioactive medication (P = 0.010). In univariate analysis NT-proBNP was significantly correlated with age (P or=30 mmHg (P or=30 mmHg (P = 0.027) were independently associated with NT-proBNP levels. Our data support the idea that measurement of plasma NT-proBNP levels in HCM patients is useful to assess their clinical status, especially the severity of hypertrophy and the presence of obstruction, although age must be taken into account
Differences in echocardiographic characteristics of functional mitral regurgitation in ischaemic versus idiopathic dilated cardiomyopathy: a pilot study.
No full textINTRODUCTION: Functional mitral regurgitation (FMR) is a common complication in patients with ischaemic (ICM) or idiopathic dilated cardiomyopathy (DCM), as a consequence of left ventricular (LV) remodelling. The aim of this study was to elucidate the differences in FMR between patients with ICM and DCM utilising conventional and tissue Doppler echocardiography. METHODS: We studied 21 patients with ICM and 17 with DCM using conventional and tissue Doppler echocardiography. The severity of FMR was assessed quantitatively and by the PISA method. The 2 groups were similar in terms of NYHA class, LV ejection fraction and pharmacological treatment. RESULTS: Patients with ICM had higher pulmonary artery systolic pressures (48 +/- 16 vs. 38 +/- 10 mmHg, p=0.04), more severe FMR as assessed by colour Doppler (1.9 +/- 0.9 vs. 1.1 +/- 0.5, p=0.006), and a larger effective regurgitant orifice (0.17 +/- 0.07 vs. 0.1 +/- 0.05 cm(2), p=0.003) and tenting area (2.3 +/- 0.8 vs. 1.7 +/- 0.7 cm(2), p=0.02). In addition, ICM subjects had lower mitral annular systolic (Sm 2.3 +/- 0.8 vs. 3.4 +/- 0.9 cm/s, p1.27 cm(2) exhibited the highest sensitivity and regurgitant volume >24 ml the highest specificity for predicting ischaemic aetiology of LV dysfunction. However, only age and Sm were independent predictors of the diagnosis of ICM rather than DCM. CONCLUSIONS: Mitral apparatus deformity, incomplete closure of mitral leaflets and global remodelling are more prominent in patients with ICM and lead to more severe FMR than in patients with DCM
Echocardiographic characteristics of functional mitral regurgitation in ischaemic versus idiopathic dilated cardiomyopathy
No full textPrognostic value of right ventricular diastolic function indices in hypertrophic cardiomyopathy
No full textLeft ventricular function in elite rowers in relation to training-induced structural myocardial adaptation.
No full textTo examine left ventricular (LV) function in elite young athletes in relation to structural adaptation to prolonged intense training. Conventional echocardiography and tissue Doppler imaging (TDI) were performed in 15 elite rowers and 12 sedentary matched controls. Rowers had increased LV mass index, septal (12 vs 10 mm, P<0.005) and posterior wall thicknesses (12 vs 9 mm, P<0.001) and increased relative wall thickness. Septal and lateral systolic velocities were enhanced in rowers (septal S(m)=8.5 vs 6.3 cm/s, P<0.001; lateral S(m)=11.4 vs 8.0 cm/s, P<0.005), representing a 35% and 42% increase, respectively. Similarly, septal and lateral early diastolic velocities were enhanced (septal E(m)=12.1 vs 9.5 cm/s, P<0.01; lateral E(m)=16.6 vs 11.6 cm/s, P<0.001), representing a 27% and 43% increase, respectively. Systolic and early diastolic TDI velocities of the lateral wall showed a positive correlation (r=0.65, P<0.01) in athletes indicating a parallel improvement of systolic and diastolic function, while LV stiffness was decreased [(E/E(m))/(LV end-diastolic diameter)=1.13 vs 1.57, P<0.005). Both systolic and diastolic LV function were improved in elite rowers, despite a pattern of concentric hypertrophy
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
No full textAims: Given the advances in atrial fibrillation (AF) management and the availability of new European Society of Cardiology (ESC) guidelines, there is a need for the systematic collection of contemporary data regarding the management and treatment of AF in ESC member countries. Methods and results: We conducted a registry of consecutive in- and outpatients with AF presenting to cardiologists in nine participating ESC countries. All patients with an ECG-documented diagnosis of AF confirmed in the year prior to enrolment were eligible. We enroled a total of 3119 patients from February 2012 to March 2013, with full data on clinical subtype available for 3049 patients (40.4% female; mean age 68.8 years). Common comorbidities were hypertension, coronary disease, and heart failure. Lone AF was present in only 3.9% (122 patients). Asymptomatic AF was common, particularly among those with permanent AF. Amiodarone was the most common antiarrhythmic agent used (~20%), while beta-blockers and digoxin were the most used rate control drugs. Oral anticoagulants (OACs) were used in 80% overall, most often vitamin K antagonists (71.6%), with novel OACs being used in 8.4%. Other antithrombotics (mostly antiplatelet therapy, especially aspirin) were still used in one-third of the patients, and no antithrombotic treatment in only 4.8%. Oral anticoagulants were used in 56.4% of CHA 2DS2-VASc = 0, with 26.3% having no antithrombotic therapy. A high HAS-BLED score was not used to exclude OAC use, but there was a trend towards more aspirin use in the presence of a high HAS-BLED score. Conclusion: The EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry has provided systematic collection of contemporary data regarding the management and treatment of AF by cardiologists in ESC member countries. Oral anticoagulant use has increased, but novel OAC use was still low. Compliance with the treatment guidelines for patients with the lowest and higher stroke risk scores remains suboptimal. © The Author 2013
Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis
No full textGaussian modeling of the P-wave morphology time course applied to anticipate paroxysmal atrial fibrillation
No full textThis paper introduces a new algorithm to quantify the P-wave morphology time course with the aim of anticipating as much as possible the onset of paroxysmal atrial fibrillation (PAF). The method is based on modeling each P-wave with a single Gaussian function and analyzing the extracted parameters variability over time. The selected Gaussian approaches are associated with the amplitude, peak timing, and width of the P-wave. In order to validate the algorithm, electrocardiogram segments 2h preceding the onset of PAF episodes from 46 different patients were assessed. According to the expected intermittently disturbed atrial conduction before the onset of PAF, all the analyzed Gaussian metrics showed an increasing variability trend as the PAF onset approximated. Moreover, the Gaussian P-wave width reported a diagnostic accuracy around 80% to discern between healthy subjects, patients far from PAF, and patients less than 1h close to a PAF episode. This discriminant power was similar to those provided by the most classical time-domain approach, i.e., the P-wave duration. However, this newly proposed parameter presents the advantage of being less sensitive to a precise delineation of the P-wave boundaries. Furthermore, the linear combination of both metrics improved the diagnostic accuracy up to 86.69%. In conclusion, morphological P-wave characterization provides additional information to the metrics based on P-wave timing.This work was supported by the projects TEC2010-20633 from the Spanish Ministry of Science and Innovation and PPII11-0194-8121 from Junta de Comunidades de Castilla La Mancha.Martínez, A.; Alcaraz, R.; Rieta, JJ. (2015). Gaussian modeling of the P-wave morphology time course applied to anticipate paroxysmal atrial fibrillation. Computer Methods in Biomechanics and Biomedical Engineering. 18(16):1775-1784. https://doi.org/10.1080/10255842.2014.964219S177517841816Abe, Y., Fukunami, M., Yamada, T., Ohmori, M., Shimonagata, T., Kumagai, K., … Hoki, N. (1997). Prediction of Transition to Chronic Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation by Signal- Averaged Electrocardiography. Circulation, 96(8), 2612-2616. doi:10.1161/01.cir.96.8.2612Barbosa, P. R. B., de Souza Bomfim, A., Barbosa, E. C., Ginefra, P., Helena Cardoso Boghossian, S., Destro, C., & Nadal, J. (2006). Spectral turbulence analysis of the signal-averaged electrocardiogram of the atrial activation as predictor of recurrence of idiopathic and persistent atrial fibrillation. International Journal of Cardiology, 107(3), 307-316. doi:10.1016/j.ijcard.2005.03.073Bollmann, A. (1999). Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG. Cardiovascular Research, 44(1), 60-66. doi:10.1016/s0008-6363(99)00156-xCarlson, J., Johansson, R., & Olsson, S. B. (2001). Classification of electrocardiographic P-wave morphology. IEEE Transactions on Biomedical Engineering, 48(4), 401-405. doi:10.1109/10.915704Censi, F., Calcagnini, G., Corazza, I., Mattei, E., Triventi, M., Bartolini, P., & Boriani, G. (2012). On the resolution of ECG acquisition systems for the reliable analysis of the P-wave. Physiological Measurement, 33(2), N11-N17. doi:10.1088/0967-3334/33/2/n11Censi, F., Calcagnini, G., Ricci, C., Ricci, R. P., Santini, M., Grammatico, A., & Bartolini, P. (2007). P-Wave Morphology Assessment by a Gaussian Functions-Based Model in Atrial Fibrillation Patients. IEEE Transactions on Biomedical Engineering, 54(4), 663-672. doi:10.1109/tbme.2006.890134CENSI, F., RICCI, C., CALCAGNINI, G., TRIVENTI, M., RICCI, R. P., SANTINI, M., & BARTOLINI, P. (2008). Time-Domain and Morphological Analysis of the P-Wave. Part I: Technical Aspects for Automatic Quantification of P-Wave Features. Pacing and Clinical Electrophysiology, 31(7), 874-883. doi:10.1111/j.1540-8159.2008.01102.xChesnokov, Y. V. (2008). Complexity and spectral analysis of the heart rate variability dynamics for distant prediction of paroxysmal atrial fibrillation with artificial intelligence methods. Artificial Intelligence in Medicine, 43(2), 151-165. doi:10.1016/j.artmed.2008.03.009Clavier, L., Boucher, J.-M., Lepage, R., Blanc, J.-J., & Cornily, J.-C. (2002). Automatic P-wave analysis of patients prone to atrial fibrillation. Medical & Biological Engineering & Computing, 40(1), 63-71. doi:10.1007/bf02347697De Bacquer, D., Willekens, J., & De Backer, G. (2007). Long-Term Prognostic Value of P-Wave Characteristics for the Development of Atrial Fibrillation in Subjects Aged 55 to 74 Years at Baseline. The American Journal of Cardiology, 100(5), 850-854. doi:10.1016/j.amjcard.2007.04.017De Vos, C. B., Pisters, R., Nieuwlaat, R., Prins, M. H., Tieleman, R. G., Coelen, R.-J. S., … Crijns, H. J. G. M. (2010). Progression From Paroxysmal to Persistent Atrial Fibrillation. Journal of the American College of Cardiology, 55(8), 725-731. doi:10.1016/j.jacc.2009.11.040Dilaveris, P. E., & Gialafos, J. E. (2001). P-Wave Dispersion: A Novel Predictor of Paroxysmal Atrial Fibrillation. Annals of Noninvasive Electrocardiology, 6(2), 159-165. doi:10.1111/j.1542-474x.2001.tb00101.xDilaveris, P. E., & Gialafos, J. E. (2002). Cardiac Electrophysiology Review, 6(3), 221-224. doi:10.1023/a:1016320807103Dubois, R., Maison-Blanche, P., Quenet, B., & Dreyfus, G. (2007). Automatic ECG wave extraction in long-term recordings using Gaussian mesa function models and nonlinear probability estimators. Computer Methods and Programs in Biomedicine, 88(3), 217-233. doi:10.1016/j.cmpb.2007.09.005Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., … Wann, L. S. (2011). 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation. Circulation, 123(10). doi:10.1161/cir.0b013e318214876dGallagher, M. M., & Camm, J. (1998). Classification of atrial fibrillation. The American Journal of Cardiology, 82(7), 18N-28N. doi:10.1016/s0002-9149(98)00736-xGANG, Y., HNATKOVA, K., MANDAL, K., GHURAN, A., & MALIK, M. (2004). Preoperative Electrocardiographic Risk Assessment of Atrial Fibrillation After Coronary Artery Bypass Grafting. Journal of Cardiovascular Electrophysiology, 15(12), 1379-1386. doi:10.1046/j.1540-8167.2004.04084.xHaïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., … Clémenty, J. (1998). Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins. New England Journal of Medicine, 339(10), 659-666. doi:10.1056/nejm199809033391003Hogue, C. W., Domitrovich, P. P., Stein, P. K., Despotis, G. D., Re, L., Schuessler, R. B., … Rottman, J. N. (1998). RR Interval Dynamics Before Atrial Fibrillation in Patients After Coronary Artery Bypass Graft Surgery. Circulation, 98(5), 429-434. doi:10.1161/01.cir.98.5.429Holmqvist, F., Platonov, P. G., Carlson, J., Zareba, W., & Moss, A. J. (2009). Altered Interatrial Conduction Detected in MADIT II Patients Bound to Develop Atrial Fibrillation. Annals of Noninvasive Electrocardiology, 14(3), 268-275. doi:10.1111/j.1542-474x.2009.00309.xIshida, K., Hayashi, H., Miyamoto, A., Sugimoto, Y., Ito, M., Murakami, Y., & Horie, M. (2010). P wave and the development of atrial fibrillation. Heart Rhythm, 7(3), 289-294. doi:10.1016/j.hrthm.2009.11.012Jurkko, R., Väänänen, H., Mäntynen, V., Kuusisto, J., Mäkijärvi, M., & Toivonen, L. (2008). High-Resolution Signal-Averaged Analysis of Atrial Electromagnetic Characteristics in Patients with Paroxysmal Lone Atrial Fibrillation. Annals of Noninvasive Electrocardiology, 13(4), 378-385. doi:10.1111/j.1542-474x.2008.00255.xKolb, C., Nürnberger, S., Ndrepepa, G., Zrenner, B., Schömig, A., & Schmitt, C. (2001). Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system. The American Journal of Cardiology, 88(8), 853-857. doi:10.1016/s0002-9149(01)01891-4Martínez, A., Alcaraz, R., & Rieta, J. J. (2010). Application of the phasor transform for automatic delineation of single-lead ECG fiducial points. Physiological Measurement, 31(11), 1467-1485. doi:10.1088/0967-3334/31/11/005Martínez, A., Alcaraz, R., & Rieta, J. J. (2012). Study on the P-wave feature time course as early predictors of paroxysmal atrial fibrillation. Physiological Measurement, 33(12), 1959-1974. doi:10.1088/0967-3334/33/12/1959Mohebbi, M., & Ghassemian, H. (2012). Prediction of paroxysmal atrial fibrillation based on non-linear analysis and spectrum and bispectrum features of the heart rate variability signal. Computer Methods and Programs in Biomedicine, 105(1), 40-49. doi:10.1016/j.cmpb.2010.07.011Papageorgiou, P., Monahan, K., Boyle, N. G., Seifert, M. J., Beswick, P., Zebede, J., … Josephson, M. E. (1996). Site-Dependent Intra-Atrial Conduction Delay. Circulation, 94(3), 384-389. doi:10.1161/01.cir.94.3.384Passman, R., Beshai, J., Pavri, B., & Kimmel, S. (2001). Predicting post–coronary bypass surgery atrial arrhythmias from the preoperative electrocardiogram. American Heart Journal, 142(5), 806-810. doi:10.1067/mhj.2001.118736Platonov, P. G. (2012). P-Wave Morphology: Underlying Mechanisms and Clinical Implications. Annals of Noninvasive Electrocardiology, 17(3), 161-169. doi:10.1111/j.1542-474x.2012.00534.xShin, D.-G., Yoo, C.-S., Yi, S.-H., Bae, J.-H., Kim, Y.-J., Park, J.-S., & Hong, G.-R. (2006). Prediction of Paroxysmal Atrial Fibrillation Using Nonlinear Analysis of the R-R Interval Dynamics Before the Spontaneous Onset of Atrial Fibrillation. Circulation Journal, 70(1), 94-99. doi:10.1253/circj.70.94SörnmoL, LagunaP. 2005. Bioelectrical signal processing in cardiac and neurological applications. Chapter 7. London, UK: Elsevier Academic Press.Sovilj, S., Van Oosterom, A., Rajsman, G., & Magjarevic, R. (2010). ECG-based prediction of atrial fibrillation development following coronary artery bypass grafting. Physiological Measurement, 31(5), 663-677. doi:10.1088/0967-3334/31/5/005Stafford, P. J., Robinson, D., & Vincent, R. (1995). Optimal analysis of the signal averaged P wave in patients with paroxysmal atrial fibrillation. Heart, 74(4), 413-418. doi:10.1136/hrt.74.4.413Thong, T., McNames, J., Aboy, M., & Goldstein, B. (2004). Prediction of Paroxysmal Atrial Fibrillation by Analysis of Atrial Premature Complexes. IEEE Transactions on Biomedical Engineering, 51(4), 561-569. doi:10.1109/tbme.2003.821030Tuzcu, V., Nas, S., Börklü, T., & Ugur, A. (2006). Decrease in the heart rate complexity prior to the onset of atrial fibrillation. EP Europace, 8(6), 398-402. doi:10.1093/europace/eul031Vassilikos, V., Dakos, G., Chatzizisis, Y. S., Chouvarda, I., Karvounis, C., Maynard, C., … Styliadis, I. (2011). Novel non-invasive P wave analysis for the prediction of paroxysmal atrial fibrillation recurrences in patients without structural heart disease. International Journal of Cardiology, 153(2), 165-172. doi:10.1016/j.ijcard.2010.08.029Vikman, S., Mäkikallio, T. H., Yli-Mäyry, S., Pikkujämsä, S., Koivisto, A.-M., Reinikainen, P., … Huikuri, H. V. (1999). Altered Complexity and Correlation Properties of R-R Interval Dynamics Before the Spontaneous Onset of Paroxysmal Atrial Fibrillation. Circulation, 100(20), 2079-2084. doi:10.1161/01.cir.100.20.2079Yang, W. Y., Cao, W., Chung, T.-S., & Morris, J. (2005). Applied Numerical Methods Using MATLAB®. doi:10.1002/047170519
The Human Affectome
No full textOver the last decades, theoretical perspectives in the interdisciplinary field of the affective sciences have proliferated rather than converged due to differing assumptions about what human affective phenomena are and how they work. These metaphysical and mechanistic assumptions, shaped by academic context and values, have dictated affective constructs and operationalizations. However, an assumption about the purpose of affective phenomena can guide us to a common set of metaphysical and mechanistic assumptions. In this capstone paper, we home in on a nested teleological principle for human affective phenomena in order to synthesize metaphysical and mechanistic assumptions. Under this framework, human affective phenomena can collectively be considered algorithms that either adjust based on the human comfort zone (affective concerns) or monitor those adaptive processes (affective features). This teleologically-grounded framework offers a principled agenda and launchpad for both organizing existing perspectives and generating new ones. Ultimately, we hope the Human Affectome brings us a step closer to not only an integrated understanding of human affective phenomena, but an integrated field for affective research
